Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesDuloxetine in the treatment of irritable bowel syndrome: an open-label pilot study
Human Psychopharmacology: Clinical and Experimental, 07/01/09
Brennan BP et al. - Open-label study, duloxetine appeared to be effective for many features of IBS, but its adverse effects, most notably constipation, limited its use. Since our study excluded individuals with concurrent major depression, it appears that duloxetine may benefit IBS independently of its antidepressant effects. These encouraging but preliminary open-label findings support further investigation of duloxetine treatment in placebo-controlled trials of IBS.
Methods- Open-label 12-week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder.
- The primary outcome measure was average abdominal pain.
- Secondary measures included IBS symptoms, Clinical Global Impression-Severity, Hamilton Anxiety Rating Scale, IBS Quality-of-Life Scale, and Sheehan Disability Scale.
- Analyzed changes using random regression and one-sample t-tests.
- Fourteen patients completed at least one post-baseline evaluation; eight completed the study.
- Duloxetine was associated with significant improvement (p < 0.05) in pain, severity of illness, quality of life, loose stool, work and family disability, and anxiety.
- However, duloxetine did not improve hard stool.
- Found no evidence of serious duloxetine toxicity, seven participants withdrew over the course of the study because of adverse drug events.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09
Pregnancy and Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/16/09
Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09
Sponsor
Article Search
Sponsor
Sponsor